Alnylam Pharmaceuticals(ALNY) - 2025 Q3 - Earnings Call Transcript

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Q3 2025 Earnings Call October 30, 2025 08:30 AM ET Company ParticipantsAdithya Jayaraman - Senior Managing DirectorPushkal Garg - Chief Research and Development OfficerJulian Pino - Biotechnology Equity Research AssociateChristine Akinc - Chief Corporate Communications OfficerJeff Poulton - CFOTazeen Ahmad - Managing Director in U.S. Equity Research of Small and Mid-cap BiotechnologyTolga Tanguler - Chief Commercial OfficerYvonne Greenstreet - CEOConference Call Parti ...